Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$37.6K Sell
813
-153
-16% -$6.17K ﹤0.01% 2931
2026
Q1
$32K Sell
966
-619
-39% -$20.1K ﹤0.01% 2899
2025
Q4
$51.9K Buy
1,585
+31
+2% +$762 ﹤0.01% 2684
2025
Q3
$27.7K Hold
1,554
﹤0.01% 2941
2025
Q2
$16.9K Hold
1,554
﹤0.01% 3237
2025
Q1
$28.7K Sell
1,554
-287
-16% -$5.18K ﹤0.01% 3010
2024
Q4
$30.3K Buy
+1,841
New +$26.1K ﹤0.01% 2977
2023
Q3
Sell
-1,137
Closed -$10.4K 3990
2023
Q2
$10.4K Hold
1,137
﹤0.01% 3244
2023
Q1
$10.7K Buy
1,137
+104
+10% +$951 ﹤0.01% 3256
2022
Q4
$10.3K Hold
1,033
﹤0.01% 3288
2022
Q3
$12K Hold
1,033
﹤0.01% 3300
2022
Q2
$8K Buy
1,033
+33
+3% +$282 ﹤0.01% 3411
2022
Q1
$8K Sell
1,000
-3,071
-75% -$26.5K ﹤0.01% 3440
2021
Q4
$38K Buy
4,071
+3,071
+307% +$36.8K ﹤0.01% 2786
2021
Q3
$16K Sell
1,000
-43
-4% -$772 ﹤0.01% 3229
2021
Q2
$23K Buy
1,043
+1,000
+2,326% +$20.2K ﹤0.01% 3056
2021
Q1
$1K Buy
+43
New +$849 ﹤0.01% 3768

Other funds holding AXGN

US Bancorp's AXGN Position: Q2 2026 in Review

US Bancorp reduced its Axogen (AXGN) stake by 16% in Q2 2026, selling an estimated $6.17K and leaving 813 shares worth $37.6K. The position accounts for ﹤0.01% of the portfolio, ranked #2931.

US Bancorp first reported a position in AXGN in Q1 2021 and has held it in 17 quarters since. The position peaked at $51.9K in Q4 2025. 253 funds tracked by Wall St. Rank hold AXGN as of Q2 2026.

  • US Bancorp held 813 shares of Axogen worth $37.6K as of Q2 2026.
  • US Bancorp sold 153 Axogen shares in Q2 2026, an estimated $6.17K.
  • Axogen made up ﹤0.01% of US Bancorp's portfolio in Q2 2026, its #2931 holding.
  • US Bancorp first reported a position in Axogen in Q1 2021 and has held it in 17 quarters since.
  • US Bancorp's Axogen position peaked at $51.9K in Q4 2025.
  • 253 funds tracked by Wall St. Rank held Axogen as of Q2 2026.

Based on US Bancorp's 13F filing for Q2 2026, filed 12 Aug 2026.